Skip to content

EMDR Intervention for Psychological Trauma Among Syrian Refugees

EMDR Treatment for Psychological Trauma Among Syrian Refugees in Kilis, Randomized Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01847742
Enrollment
80
Registered
2013-05-07
Start date
2013-04-30
Completion date
2014-02-28
Last updated
2013-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychological Trauma

Brief summary

To implement an EMDR (Eye Movement Desensitization and Reprocessing)intervention to treat the trauma symptoms among Syrian Refugees.

Detailed description

In this project we aim to treat the posttraumatic stress disorder (PTSD) symptoms among Syrian refugees through an effective psycho-therapy technique called Eye Movement Desensitization and Reprocessing (EMDR). Randomly selected refugees will be assessed through MINI PLUS for the diagnose of PTSD. Eighty refugees with PTSD will be randomly allocated to either 7 sessions EMDR or wait-list control group.Symptoms of PTSD (MINI PLUS, HTQ, IES-R) and depression and anxiety (BDI, HSCL)will be assessed at pre- and post-treatment and 4 weeks follow-up. However, to our knowledge this is one of the first intervention studies which will be conducted in a refugee camp. Therefore we expect to have some practical and logical problems. In order to see the feasibility and efficacy of EMDR among Syrian refugees, before the main study we aim to run a pilot study with less participants. In the pilot we will assess the posttraumatic stress symptoms with Impact of Event Scale-Revised (IES-R) and the depressive symptoms through Beck Depression Inventory (BDI-II).

Interventions

Sponsors

Istanbul Sehir University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* trauma symptoms

Exclusion criteria

* pregnancy * current or past psychotic disorder * current or past substance abuse or dependence * serious physical illness * active suicidal ideation

Design outcomes

Primary

MeasureTime frameDescription
score on Harvard Trauma Questionnaire (at the main study)before and after the treatment,an expected average of 7 weeks of EMDR treatmentThe change in HTQ score will be assessed after the EMDR treatment has finished after 7 weeks(estimated).
Impact of Event Scale Revised (at the pilot study and the main study)pre- and post treatmentThe change in IES-R score will be assessed after the EMDR treatment has finished after 7 weeks(estimated).

Secondary

MeasureTime frameDescription
score on HSCL for depressive and anxiety symptoms (at the main study)before and after the treatment, an expected average of 7 weeks of EMDR treatmentThe change in HSCL score will be assessed after the EMDR treatment has finished in 7 weeks in average.
Score on BDI-II (pilot study and the main study)before and after EMDR treatment, an expected average of 7 weeks of EMDR treatmentA change in BDI-II will be assessed after the EMDR treatment has completed in 7 weeks.

Countries

Turkey (Türkiye)

Contacts

Primary ContactCeren Acarturk, PhD
cerenacarturk@sehir.edu.tr0090216444 4034

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026